The Official Methodology Will Quantify Emissions Reductions from the Production of Biochar OTTAWA, Ontario--(BUSINESS WIRE)--#Biochar--Invert Inc. ("Invert" or “the Company"), a specialized carbon reduction and offsetting company focused on making car
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE AMERICAN:CYBN) (“Cybin” or the “Company”), a biotechnology company focused on progressing Psychedelics to Therapeutics™, is pleased to announce that Adelia Therapeutics Inc. (“Adelia”), a
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a neuroscience-focused biotechnology company developing next-generation, psychedelic-inspired mental health medicines, today announced that A
Case IH and Raven Industries collaborate to deliver an advanced, driverless spreading solution BOONE, Iowa--(BUSINESS WIRE)--#DriverlessAgTechnology--Case IH and Raven Industries introduce the agriculture industry’s first autonomous spreader: the Case
OK-101 to treat ocular diseases, including Dry Eye Disease (DED), uveitis, allergic conjunctivitis, and ocular pain. Successful pre-IND meeting with FDA in Q1 2022 and novel speed to market potential. IND filing on OK-101 to treat DED planned for Q4
- Clinical milestone marks initiation of first ever novel psilocybin analog to enter clinical development – TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on
RICHMOND, British Columbia--(BUSINESS WIRE)--Fine Choice Foods, a market-leading producer of quality Asian-inspired foods, announced the opening of its second manufacturing facility, also located in Richmond, with a recent in-person celebration. The event
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES SASKATOON, Saskatchewan & LONDON--(BUSINESS WIRE)--Gensource Potash Corporation (“Gensource” or the “Company”) (AIM/TSXV: GSP), a fertilizer development company
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, confirms that the Ontario Securities Commission (the “OS
Executive changes announced in support of the Corporation Growth Phase: Ms. Sybil Dahan takes on the role of Devonian’s Chairperson of the Board of Directors Mr. Pierre Montanaro takes on the role of Devonian’s President & CEO. Dr André P
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.